BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201103
DTEND;VALUE=DATE:20201106
DTSTAMP:20260515T133201
CREATED:20200803T075703Z
LAST-MODIFIED:20200803T094758Z
UID:26593-1604361600-1604620799@www.pharmajournalist.com
SUMMARY:Digital 5th Neoantigen Based Therapies Summit
DESCRIPTION:With all eyes on the explosive neoantigen field watching to see how it can revolutionize cancer immunotherapies and rival the current T cell therapies\, it is clear that critical questions still remain to be addressed to ensure full therapeutic success. \n \nTaking place from the comfort of your own home this year\, the 5th Neoantigen Based Therapies Summit remains the only industry focused meeting dedicated to the full end-to-end development and commercialization of neoantigen-based cancer immunotherapies. \nView the full event guide for more details on this content packed 3-day virtual event. \nWe’ll be addressing the most pressing challenges in the field\, including: \n\nIdentifying both personalized and shared Neoantigens to supercharge development of next generation immunotherapy with University of Miami and Netherlands Cancer Institute\nImproving prediction accuracy by exploring different neoantigen sources with Ervaxx\, Precision Biologics and Broad Institute\nHow to maximize immunogenicity to drive clinical development & success with Gritstone Oncology\, Genocea and Treos Bio\nReducing complex process and release times by navigating through complex manufacturing challenges with Achilles Therapeutics\, Vaximm and ISA Therapeutics\n\nDownload the official brochure to see what sessions will help you to advance your cancer immunotherapy pipeline. \nJoin us online to gain the practical insights you need to improve the immune response and commercial viability of your neoantigen based cancer immunotherapy.
URL:https://www.pharmajournalist.com/event/digital-5th-neoantigen-based-therapies-summit/
LOCATION:Online | Digital Event
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR